Nifty

:

23398.10

Sensex

:

74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Login

Nifty
Sensex

:
:

23398.10
74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Pfizer Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

55/99

BSE: 500680 | NSE: PFIZER

Watchlist

NSE BSE

4060.20

11-Sep-2026

Open
High
Low
Previous Close

4103.1
4123.8
4054
4095.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

138685
564336664.1
5578.5
4054

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

18,582.96
25.28
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

15,474.70
1.85%
4.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.51
-0.71
4.73

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.95
1.58
7.31

PAT CAGR (%)

10 Years
5 Years
3 Years

7.93
3.35
9.43

P:E (Median)

8 Years
5 Years
3 Years

34.69
32.72
31.90

P:BV (Average)

8 Years
5 Years
3 Years

6.74
6.21
5.74

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.54
21.22
21.37

Earnings Forecasts:

(Updated: 12-09-2026)

Description 2026 2027 2028 2029
Adj EPS 64 -33 10.33 162.75
P/E Ratio 63.44 -123.04 393.05 24.95
Revenue 24.74 22.41 - 2519.07
EBITDA 2742.93 2977.53 - 893.4
Net Income 967.2 1058.23 - 745.5
ROA 820.83 906.43 - 19.64
P/B Ratio -1.16 -0.99 - 3.95
ROE 4.29 3.8 - 17.67
FCFF 18.17 17.75 - 837.9
FCFF Yield 657.95 773.05 - 4.85
Net Debt 3.81 4.48 - -
BVPS -3493.85 -4116.05 - 1028.66

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 653.17 603.05 8.31% 629.23 591.91 6.31% 645.03 537.99 19.90% 642.34 588.59 9.13%
Expenses 405.61 393.03 3.20% 393.28 364.41 7.92% 416.84 392.00 6.34% 412.41 399.34 3.27%
EBITDA 247.56 210.02 17.87% 235.95 227.50 3.71% 228.19 145.99 56.31% 229.93 189.25 21.50%
EBIDTM 37.90% 34.83% 37.50% 38.43% 35.38% 27.14% 35.80% 32.15%
Other Income 44.84 67.17 -33.24% 40.72 44.58 -8.66% 38.21 42.76 -10.64% 41.85 43.07 -2.83%
Interest 1.46 3.25 -55.08% 2.11 2.69 -21.56% 1.99 1.51 31.79% 2.13 2.10 1.43%
Depreciation 14.26 14.41 -1.04% 14.78 16.40 -9.88% 14.26 14.80 -3.65% 14.28 14.99 -4.74%
PBT 276.68 259.53 6.61% 268.82 425.80 -36.87% 191.95 172.44 11.31% 255.37 215.23 18.65%
Tax 72.21 67.78 6.54% 69.00 94.86 -27.26% 50.11 44.84 11.75% 66.35 56.88 16.65%
PAT 204.47 191.75 6.63% 199.82 330.94 -39.62% 141.84 127.60 11.16% 189.02 158.35 19.37%
PATM 31.30% 31.80% 31.76% 55.91% 21.99% 23.72% 29.43% 26.90%
EPS 44.74 41.96 6.63% 43.72 72.42 -39.63% 31.04 27.92 11.17% 41.36 34.65 19.37%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,569.77 2,519.65 2,281.35 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65 2,081.50 1,968.51 1,966.26 Net Sales Growth 10.69% 10.45% 4.02% -9.55% -7.13% 16.64% 4.04% 3.37% 5.74% 0.11% Cost Of Goods Sold 913.19 827.97 755.56 729.77 802.73 875.65 734.29 741.69 678.48 677.55 711.67 Gross Profit 1,656.58 1,691.68 1,525.79 1,463.40 1,622.03 1,735.34 1,504.26 1,409.96 1,403.02 1,290.96 1,254.59 GP Margin 64.46% 67.14% 66.88% 66.73% 66.89% 66.46% 67.20% 65.53% 67.40% 65.58% 63.81% Total Expenditure 1,628.14 1,615.47 1,541.03 1,557.85 1,615.81 1,775.05 1,526.15 1,578.93 1,515.87 1,467.87 1,616.13 Power & Fuel Cost - 3.20 3.48 3.98 6.51 5.67 5.79 11.04 11.45 12.34 10.34 % Of Sales - 0.13% 0.15% 0.18% 0.27% 0.22% 0.26% 0.51% 0.55% 0.63% 0.53% Employee Cost - 367.97 371.33 347.80 331.68 403.67 361.06 364.51 323.84 314.29 303.89 % Of Sales - 14.60% 16.28% 15.86% 13.68% 15.46% 16.13% 16.94% 15.56% 15.97% 15.46% Manufacturing Exp. - 114.35 105.43 113.97 122.57 132.19 123.71 104.97 131.96 118.74 151.54 % Of Sales - 4.54% 4.62% 5.20% 5.05% 5.06% 5.53% 4.88% 6.34% 6.03% 7.71% General & Admin Exp. - 137.82 142.48 158.53 158.87 162.66 130.80 165.96 182.49 173.38 234.11 % Of Sales - 5.47% 6.25% 7.23% 6.55% 6.23% 5.84% 7.71% 8.77% 8.81% 11.91% Selling & Distn. Exp. - 122.14 117.57 159.43 139.16 148.11 137.87 153.70 152.83 143.35 152.82 % Of Sales - 4.85% 5.15% 7.27% 5.74% 5.67% 6.16% 7.14% 7.34% 7.28% 7.77% Miscellaneous Exp. - 42.02 45.18 44.37 54.29 47.10 32.63 37.06 34.82 28.22 152.82 % Of Sales - 1.67% 1.98% 2.02% 2.24% 1.80% 1.46% 1.72% 1.67% 1.43% 2.63% EBITDA 941.63 904.18 740.32 635.32 808.95 835.94 712.40 572.72 565.63 500.64 350.13 EBITDA Margin 36.64% 35.89% 32.45% 28.97% 33.36% 32.02% 31.82% 26.62% 27.17% 25.43% 17.81% Other Income 165.62 187.95 172.25 180.51 101.05 62.65 81.12 184.02 167.39 114.29 101.16 Interest 7.69 9.57 8.50 15.43 13.48 10.70 15.39 11.01 1.72 0.77 1.96 Depreciation 57.58 57.73 60.79 62.28 105.51 115.00 109.41 103.24 71.39 66.25 62.93 PBT 992.82 1,024.83 843.28 738.12 791.01 772.89 668.72 642.49 659.91 547.91 386.40 Tax 257.67 253.24 248.49 194.74 200.08 160.33 171.11 133.36 230.86 187.84 180.05 Tax Rate 25.95% 25.96% 24.46% 26.10% 24.28% 20.74% 25.59% 20.76% 34.98% 34.28% 34.84% PAT 735.15 722.43 767.60 551.33 623.93 612.56 497.61 509.13 429.05 360.07 336.78 PAT before Minority Interest 735.15 722.43 767.60 551.33 623.93 612.56 497.61 509.13 429.05 360.07 336.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 28.61% 28.67% 33.65% 25.14% 25.73% 23.46% 22.23% 23.66% 20.61% 18.29% 17.13% PAT Growth -9.09% -5.88% 39.23% -11.64% 1.86% 23.10% -2.26% 18.66% 19.16% 6.92% EPS 160.86 158.08 167.96 120.64 136.53 134.04 108.89 111.41 93.88 78.79 73.69

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 4,202.90 4,217.41 3,595.54 3,207.30 2,864.41 2,393.04 3,395.49 3,011.34 2,683.20 2,418.88 Share Capital 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 Total Reserves 4,157.15 4,171.66 3,549.79 3,161.55 2,818.66 2,347.29 3,349.74 2,965.59 2,637.45 2,373.13 Non-Current Liabilities 19.19 54.89 32.74 38.41 136.23 85.06 135.93 36.96 52.32 62.41 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 48.10 56.57 32.33 42.76 55.47 55.84 47.87 34.73 37.74 44.85 Current Liabilities 627.48 569.51 546.56 657.35 852.89 774.34 873.36 891.69 954.44 779.67 Trade Payables 215.94 151.60 166.23 217.06 263.94 283.74 426.78 435.92 495.63 388.00 Other Current Liabilities 146.81 143.11 172.80 176.49 345.92 361.47 340.37 294.19 302.29 241.36 Short Term Borrowings 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 Short Term Provisions 262.23 272.30 205.03 261.30 240.53 126.63 103.71 159.08 154.02 147.81 Total Liabilities 4,849.57 4,841.81 4,174.84 3,903.06 3,853.53 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 Net Block 677.97 723.62 712.71 749.25 840.96 864.74 941.91 853.86 916.60 867.08 Gross Block 1,417.93 1,418.48 1,355.73 1,352.40 1,345.28 1,278.52 1,277.00 1,100.27 1,094.86 983.27 Accumulated Depreciation 739.96 694.86 643.02 603.15 504.32 413.78 335.09 246.41 178.26 116.19 Non Current Assets 1,046.35 1,328.96 1,405.28 1,377.97 1,457.05 1,343.96 1,356.53 1,224.63 1,273.24 1,209.65 Capital Work in Progress 20.00 7.64 0.40 7.93 1.15 2.76 0.76 0.00 1.04 15.35 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 291.21 541.34 589.78 550.26 549.20 291.62 255.26 225.11 236.25 226.29 Other Non Current Assets 57.17 56.36 102.39 70.53 37.57 155.28 127.65 113.33 85.63 65.82 Current Assets 3,803.22 3,512.85 2,737.81 2,493.34 2,361.44 1,873.30 3,013.07 2,701.68 2,403.04 2,032.50 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 472.66 475.92 433.69 417.70 448.90 435.05 430.59 386.66 297.06 321.90 Sundry Debtors 181.80 193.09 187.61 151.73 142.55 108.77 172.03 171.66 154.80 110.32 Cash & Bank 3,110.76 2,800.98 2,046.71 1,859.52 1,643.44 1,115.10 2,219.87 1,914.34 1,771.86 1,523.09 Other Current Assets 38.00 13.74 21.31 21.79 126.55 214.38 190.58 229.02 179.32 77.19 Short Term Loans & Adv. 26.27 29.12 48.49 42.60 103.53 18.43 25.82 29.80 45.96 52.48 Net Current Assets 3,175.74 2,943.34 2,191.25 1,835.99 1,508.55 1,098.96 2,139.71 1,809.99 1,448.60 1,252.83 Total Assets 4,849.57 4,841.81 4,143.09 3,871.31 3,818.49 3,217.26 4,369.60 3,926.31 3,676.28 3,242.15

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 967.57 659.75 256.84 355.68 667.08 427.33 323.18 97.81 331.80 328.82 PBT 975.67 1,016.09 746.07 824.01 772.89 668.72 642.49 659.91 547.91 516.83 Adjustment -62.82 -245.57 -89.32 -131.26 76.17 54.53 -53.56 -79.47 -32.98 -153.93 Changes in Working Capital 40.19 45.45 -246.09 -34.49 43.94 -91.78 -52.46 -245.07 10.48 148.91 Cash after chg. in Working capital 953.04 815.97 410.66 658.26 893.00 631.47 536.47 335.37 525.41 511.81 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 14.53 -156.22 -153.82 -302.58 -225.92 -204.14 -213.29 -237.56 -193.61 -182.99 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -561.67 -71.34 53.70 -36.05 -575.02 -468.84 1,530.32 35.12 -238.31 -249.64 Net Fixed Assets -11.81 -69.99 4.20 -13.90 -65.15 -3.52 -177.49 -4.37 -97.28 -14.72 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -549.86 -1.35 49.50 -22.15 -509.87 -465.32 1,707.81 39.49 -141.03 -234.92 Cash from Financing Activity -798.31 -205.34 -235.14 -345.79 -180.51 -1,571.07 -163.52 -109.85 -110.35 -82.59 Net Cash Inflow / Outflow -392.41 383.07 75.40 -26.16 -88.45 -1,612.58 1,689.98 23.08 -16.86 -3.41 Opening Cash & Equivalents 495.07 112.00 36.60 62.76 151.21 1,763.79 73.81 50.73 67.59 71.05 Closing Cash & Equivalent 102.66 495.07 112.00 36.60 62.76 151.21 1,763.79 73.81 50.73 67.59

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 918.67 921.84 785.91 701.05 626.10 523.07 742.18 658.22 586.49 528.72 ROA 14.91% 17.03% 13.65% 16.09% 17.24% 13.00% 12.20% 11.25% 10.36% 10.95% ROE 17.16% 19.65% 16.21% 20.55% 23.30% 17.19% 15.89% 15.07% 14.11% 14.70% ROCE 23.39% 26.21% 22.37% 27.56% 29.78% 23.62% 20.38% 23.22% 21.49% 22.62% Fixed Asset Turnover 1.85 1.72 1.71 1.90 2.07 1.75 1.81 1.90 1.91 2.08 Receivable days 26.06 29.10 26.74 20.98 16.89 22.89 29.15 28.62 24.43 22.58 Inventory Days 65.95 69.53 67.09 61.77 59.41 70.57 69.32 59.95 57.05 61.01 Payable days 81.01 76.77 95.85 109.36 114.15 176.59 102.95 115.62 121.93 93.70 Cash Conversion Cycle 11.00 21.86 -2.02 -26.61 -37.84 -83.13 -4.48 -27.05 -40.45 -10.12 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 102.95 120.54 49.35 62.13 73.23 44.45 59.36 384.67 712.57 264.69

Description Nov 08 Nov 07 Nov 06 Nov 05
Book Value (Rs.) 301.96 216.74 142.90 113.68 ROA 18.37% 26.37% 10.07% 9.39% ROE 38.71% 63.36% 27.78% 22.90% ROCE 54.15% 84.11% 42.50% 35.52% Fixed Asset Turnover 5.62 5.16 4.71 4.43 Receivable days 28.15 30.12 35.19 39.05 Inventory Days 50.96 44.60 43.53 41.49 Payable days 69.16 84.39 92.33 80.44 Cash Conversion Cycle 9.95 -9.68 -13.61 0.09 Total Debt/Equity 0.00 0.00 0.00 0.00 Interest Cover 0.00 0.00 2275.76 712.58

Top Investors:

nippon life india trustee ltd

life insurance corporation of india

icici prudential fund

quant mutual fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Pfizer - Quarterly Results
29th Jul 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback